e-learning
resources
Monograph
2010
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Exhaled volatile organic compounds as biomarkers for respiratory diseases
P.J. Mazzone
Source:
Eur Respir Monogr 2010; 49: 130-139
Journal Issue:
Exhaled Biomarkers
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P.J. Mazzone. Exhaled volatile organic compounds as biomarkers for respiratory diseases. Eur Respir Monogr 2010; 49: 130-139
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Monitoring of pediatric asthma by symptoms and lung function versus symptoms, lung function and exhaled NO
Source: Annual Congress 2004 - Monitoring childhood asthma
Year: 2004
Volatile organic compounds of exhaled breath in lung cancer and lung inflammatory diseases
Source: Annual Congress 2013 –Epidemiology, screening and diagnosis of lung cancer
Year: 2013
Exhaled breath condensate (EBC): what is sampled and how should it be collected? (recommendations and open issues)
Source: Annual Congress 2007 - ERS/ATS joint symposium: the report of the ERS/ATS Task Force on Exhaled Breath Condensate
Year: 2007
Novel lung function tests in patients with interstitial lung disease (ILD)
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Canine scent detection in the diagnosis of lung cancer: revisiting a puzzling phenomenon
Source: Eur Respir J 2012; 39: 669-676
Year: 2012
Correlation between lung function and exhaled breath condensate biomarkers of inflammation in pulmonary diseases
Source: Annual Congress 2009 - Lung function in adults and children
Year: 2009
Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD
Source: Eur Respir J 2011; 38: 1301-1309
Year: 2011
Clinically relevant early functional and diagnostic markers of lung disease in children
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=120
Year: 2006
Surfactant protein B polymorphisms, pulmonary function and COPD in 10,231 individuals
Source: Eur Respir J 2011; 37: 791-799
Year: 2011
Using exhaled breath profiles in the discrimination between COPD, lung cancer and their co-morbidity
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015
The clinical significance of growth factors measurement in exhaled breath condensates (EBC) among patients with interstitial lung diseases
Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease
Year: 2010
Lung function and sputum neutrophil changes in an experimental model of virus-induced COPD exacerbations
Source: Annual Congress 2005 - COPD: role of infection
Year: 2005
Exhaled carbon monoxide correlates with airway neutrophilia in patients with chronic allograft dysfunction (BOS) after lung transplantation
Source: Annual Congress 2007 - New insights into clinical lung transplantation
Year: 2007
Total desmosines in plasma and urine correlate with lung function
Source: Eur Respir J 2012; 39: 839-845
Year: 2012
Analysis of semi-volatile organic compounds in exhaled breath condensate of patients with obstructive lung diseases
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010
Exhaled carbon monoxide measurement in patients with interstitial lung diseases (ILD)
Source: Annual Congress 2008 - Clinical aspects of interstitial lung disease
Year: 2008
Exhaled breath condensate biomarkers in COPD
Source: Eur Respir J 2008; 32: 472-486
Year: 2008
Myeloperoxidase in exhaled breath condensate reflects the status of lung parenchyma during the exacerbation of chronic obstructive pulmonary disease
Source: Eur Respir J 2005; 26: Suppl. 49, 54s
Year: 2005
Volatile organic compounds in exhaled breath of patients with COPD ± lung cancer and their correlation with FEV1-values
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Respiratory work and its components during exercise in interstitial lung disease, COPD and controls
Source: International Congress 2015 – Respiratory muscles and airways function: from physiology to clinical implications
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept